Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
62°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lexicon Pharmaceuticals, Inc. - Common Stock
(NQ:
LXRX
)
0.3665
+0.0095 (+2.66%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Lexicon Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
What Analysts Are Saying About Lexicon Pharmaceuticals Stock
March 07, 2025
Via
Benzinga
Here are the top movers in Monday's session.
March 03, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
March 03, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Which stocks are gapping on Monday?
March 03, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
Lexicon Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
January 29, 2025
Via
Benzinga
Analyst Expectations For Lexicon Pharmaceuticals's Future
December 23, 2024
Via
Benzinga
Demystifying Lexicon Pharmaceuticals: Insights From 10 Analyst Reviews
November 13, 2024
Via
Benzinga
Earnings Scheduled For March 6, 2025
March 06, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Preview: Lexicon Pharmaceuticals's Earnings
November 11, 2024
Via
Benzinga
The Analyst Landscape: 11 Takes On Lexicon Pharmaceuticals
November 05, 2024
Via
Benzinga
Lexicon Pharmaceuticals (LXRX) Stock Is Down: What's Going On?
March 03, 2025
Lexicon Pharmaceuticals shares are trading lower by 48% Monday morning. The company earlier announced topline results from its PROGRESS Phase 2b study evaluating pilavapadin.
Via
Benzinga
Monday's pre-market session: top gainers and losers
March 03, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
9 Health Care Stocks With Whale Alerts In Today's Session
January 28, 2025
Via
Benzinga
2 Generic Drug Stocks Ready to Surge in 2025
November 27, 2024
Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.
Via
MarketBeat
Topics
Government
Intellectual Property
Exposures
Intellectual Property
Political
Product Safety
Beyond The Numbers: 7 Analysts Discuss Lexicon Pharmaceuticals Stock
September 27, 2024
Via
Benzinga
The Analyst Verdict: Lexicon Pharmaceuticals In The Eyes Of 8 Experts
September 03, 2024
Via
Benzinga
Analyst Scoreboard: 6 Ratings For Lexicon Pharmaceuticals
August 13, 2024
Via
Benzinga
What You Missed On Wall Street This Past Friday
November 03, 2024
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.
Via
Talk Markets
Crude Oil Moves Higher; Apple Shares Slide After Q4 Results
November 01, 2024
Via
Benzinga
Exposures
Fossil Fuels
12 Health Care Stocks Moving In Friday's Intraday Session
November 01, 2024
Via
Benzinga
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
November 01, 2024
Via
Benzinga
5 Analysts Have This To Say About Lexicon Pharmaceuticals
August 02, 2024
Via
Benzinga
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
November 01, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
November 01, 2024
Via
Benzinga
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
November 01, 2024
Lexicon Pharmaceuticals' sotagliflozin, under review as an adjunct to insulin for type 1 diabetes and CKD, faced an FDA panel vote against approval, with mixed expert support.
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 01, 2024
Via
Benzinga
Deep Dive Into Lexicon Pharmaceuticals Stock: Analyst Perspectives (9 Ratings)
October 23, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Lexicon Pharmaceuticals Through Analyst Insights
October 17, 2024
Via
Benzinga
Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
August 02, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.